Govoptes

HRES 928 · Affirming support for most-favored-Nation drug pricing for United States patients.

Referred to the House Committee on Energy and Commerce.

Introduced
Dec 4, 2025
Latest action
Dec 4, 2025
Sponsor
Rep. Debbie Dingell [D-MI-6]
Policy area
Health
Cosponsors
1

Recent actions

  1. Dec 4, 2025 Referred to the House Committee on Energy and Commerce.
  2. Dec 4, 2025 Submitted in House
  3. Dec 4, 2025 Submitted in House

Votes

No recorded votes are available for this bill.

Related pages